Both in Biotechnology
Kyverna Therapeutics vs Eikon Therapeutics
Over the past year KYTX returned −6.5% and EIKN returned −46.4%; their daily moves had a correlation of 0.31.
KYTX −6.5% EIKN −46.4%Growth of $1, one year, split-adjusted
| Metric | KYTX | EIKN |
|---|---|---|
| Price | $6.80 | $8.04 |
| Market cap | $420.5M | $435.5M |
| Today | −0.58% | +1.64% |
| 1 month | −19.8% | −23.1% |
| 6 months | −21.2% | −24.0% |
| Year to date | −27.7% | — |
| 1 year | +14.5% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $174.4M | $531.2M |
| Dividend yield | — | — |
| Volatility (60d) | 64.8% | 83.5% |
| Short % of float | 23.8% | 17.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).